Senior insider sale
CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$184.9K
5K shares
What this filing means
VIVALDI COELHO ROGERIO plans to sell 5K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $184.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/12/2026ACC: 0001950047-26-002543
Director
Since Jan 2022
5K
Shares to sell
$184.9K
Approx. market value
5K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Open Market Purchase
Cash
6/8/2023
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/8/2023 | Open Market Purchase Cash | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5K
Market value
$184.9K
3/12/2026
Total
Units
5K
Value
$184.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/12/2026 | 5K | $184.9K | NASDAQ | Planned |
| Total | 5K | $184.9K | ||